The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans

J Infect. 2022 May;84(5):e53-e54. doi: 10.1016/j.jinf.2022.03.001. Epub 2022 Mar 6.
No abstract available

Keywords: ACE2; COVID-19; Hong Kong; SARS-CoV-2; Spike, selective advantage, hamsters; humans.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Animals
  • COVID-19*
  • Cricetinae
  • Humans
  • Protein Binding
  • SARS-CoV-2* / genetics
  • Spike Glycoprotein, Coronavirus

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants